Ignite Creation Date:
2024-05-05 @ 5:10 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00391638
Status:
COMPLETED
Last Update Posted:
2015-01-15
First Post:
2006-10-23
Brief Title:
Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
ANRS Emerging Infectious Diseases
Organization Data
Organization:
ANRS Emerging Infectious Diseases
Class:
OTHER_GOV
Study ID:
2006-004137-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Roche Pharma AG | INDUSTRY |
| Gilead Sciences | INDUSTRY |